BridgeMD
Compares treatment options for Adenomyosis
Official title Comparing Efficacy of Microwave Vs Embolization Treatment for Adenomyosis
ClinicalTrials.gov ID: NCT04209127
What this study is testing
- What it's testing
- Single blinded randomized controlled study of symptom improvement after uterine artery embolization (UAE) versus ultrasound guided percutaneous/transvaginal microwave ablation, evaluated by validated questionnaires. Adenomyosis is a benign condition causing pain and bleeding disorders in many women.
- Time commitment: about 1 month
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 55, women only
You may be able to join if
- Healthy women aged 30-55 with symptomatic adenomyosis
- Premenopausal
- Adenomyosis diagnosted by TVUS
- Willing to comply with protocol
You likely can't join if
- Body Mass Index \>35
- Treatment with anticoagulant/bleeding disorder
- Contraindication for UAE or general anesthesia
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Sweden
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 1 month per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 30 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.